Health2 years ago
Pitavastatin calcium is associated with a 35% reduction in CVD risk in HIV-infected people
REPRIEVE Study — A large global trial investigating the effects of daily statins HIV Low to moderate risk of cardiovascular disease (CVD) – ahead of schedule...
Recent Comments